Seoul National University Hospital
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Pharmacogenetic Study in Patients Received Iron Chelating Agent
Completed
- Conditions
- Hemosiderosis
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01623895
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Chongno-gu, Korea, Republic of
Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1
- Conditions
- Gastric Cancer
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01621919
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, GYeonggi-do, Korea, Republic of
Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
- Conditions
- Multivessel Coronary Artery Disease
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2017-08-25
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 1136
- Registration Number
- NCT01621438
- Locations
- 🇯🇵
Aichi Medical university hospital, Nagakute, Japan
🇯🇵Tokyo medical college hospital, Tokyo, Japan
🇯🇵Wakayama medical university, Wakayama, Japan
Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria
- Conditions
- Nontuberculosis Mycobacterial Lung Disease
- First Posted Date
- 2012-06-12
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT01616745
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
GlideScope®Video Laryngoscope for Difficult Intubation: Implication of the Size of Blade
Not Applicable
Completed
- Conditions
- Intubation; Difficult
- Interventions
- Device: Macintosh laryngoscopeDevice: GVL selected by weightDevice: smaller sized GVL
- First Posted Date
- 2012-06-12
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT01616771
Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population
Completed
- Conditions
- Asymptomatic General PopulationMicroscopic Hematuria
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2012-08-28
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 60048
- Registration Number
- NCT01615315
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™
Phase 4
Completed
- Conditions
- Intervertebral Disk DisplacementOssification of Posterior Longitudinal LigamentIntervertebral Disk Degeneration
- Interventions
- Device: Cervios ChronOsDevice: Bonion
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 85
- Registration Number
- NCT01615328
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Lung Deflation in Pediatric Subclavian Vein Catheterization
Not Applicable
Completed
- Conditions
- Pediatric Subclavian Vein Catheterization
- Interventions
- Procedure: lung deflationProcedure: lung inflation
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2013-04-23
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT01608503
- Locations
- 🇰🇷
Seoul national university hospital, Seoul, Korea, Republic of
Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)
Phase 4
- Conditions
- Coronary Artery Disease
- Interventions
- Device: XIENCE PRIMETM everolimus-eluting coronary stent
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2012-05-25
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT01605721
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
Phase 3
Completed
- Conditions
- Dry EyeSjogren's SyndromeAutoimmune Diseases
- Interventions
- Drug: HydroxychloroquineDrug: Placebo
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2013-10-17
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT01601028
- Locations
- 🇰🇷
Seoul National Unversity Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath